GlassScriptPhysician profile
Michael A Brown
NPI 1760500987
$16,670.95
in general payments reported to CMS, 2019-2025
38 companies · $1,255 in 2025
The $1,255 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,268 · 2020: $707 · 2021: $6,141 · 2022: $3,098 · 2023: $2,756 · 2024: $1,446 · 2025: $1,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,976 · Travel and Lodging: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,975.54 |
| Travel and Lodging | $480.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $7,996.14 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $1,080.37 | 2019-2024 | Jeti Peripheral Catheter, Jeti, Amplatzer |
| Biotronik INC. | $1,057.00 | 2019-2024 | Biomonitor, Rivacor 7 Dr-T, Edora 8 Dr-T |
| Amgen INC. | $841.65 | 2019-2025 | Repatha |
| Medtronic, INC. | $642.77 | 2021-2025 | Onyx Frontier, Symplicity G3, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $492.55 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Rotapro |
| Novartis Pharmaceuticals Corporation | $475.88 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $461.11 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $416.48 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $391.06 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $354.69 | 2023-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Abiomed | $338.74 | 2022-2025 | Impella |
| Medtronic Vascular, INC. | $251.95 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.76 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $182.50 | 2022-2025 | Eliquis, Camzyos |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.